Shots: Abbott has received the US FDA’s EUA for its molecular point-of-care test to detect novel COVID-19 and runs on its ID NOW platform, delivering positive results in just five […]readmore
Tags : Novel
Shots: The collaboration follows the existing partnership b/w J&J and BARDA while the company expects to initiate the clinical studies of selected vaccine candidates by Sept’2020 with the anticipated first […]readmore
Shots: Translate Bio will utilize its mRNA platform to discover, design, and manufacture SARS-CoV-2 vaccine candidates while Sanofi will provide its vaccine expertise in advancing the vaccine candidates for further […]readmore
The US FDA has approved multiple NDAs and BLAs in Feb 2020, leading to treatments for patients and advances in health care The Center for Drug Evaluation and Research (CDER) […]readmore
Shots: Sorrento is working with the FDA’s Center for Biologics Evaluation and Research to get guidance on the development of the novel I-Cel COVID-19 cellular vaccine. Post receiving FDA’s guidance, […]readmore
Shots: The collaboration leverages Sorrento’s mAb against SARS-CoV-2 virus that will be encoded into a gene for delivery utilizing SmartPharm’s non-viral nanoparticle platform The companies are expected to develop a […]readmore
Shots: Codexis to receive an upfront payment, reimbursement for research and development fees, development and commercial milestones along with royalties on sales of any commercial product developed under the collaboration […]readmore
Shots: Curadev to receive upfront, research funding, pre-clinical, clinical and commercial milestones of $266.9M along with royalties on sales. Bayer to gain exclusive access to novel molecules from Curadev, designed […]readmore
Shots: The collaboration will combine Iktos’ generative modeling AI technology with SRI’s SynFini synthetic chemistry platform to develop optimized compound & to facilitate the identification of drug therapies treating multiple […]readmore
Shots: Nimble to receive up front, milestones & royalties on sales of the therapies developed under the collaboration. The collaboration will accelerate the discovery of novel therapies targeting multiple diseases […]readmore